Do You Need a Virus Passport?

The CDC issued newly updated guidance on Covid-19 that did not come as a surprise. Meanwhile, the President-Elect named a new Treasury Secretary. In the CDC’s statement, it said… Read more

Tesla Motors: The Next $1 Trillion Stock?

$1 trillion. That could be the total market capitalization of Tesla Motors (NASDAQ: TSLA). That’s IF Tesla stock reaches a newly issued $1,000 per share price target. That price… Read more

Preview: The Top 4 IPOs for December 2020

After a wave of IPO filings in November, a rush of companies will go public right after Thanksgiving. And the latest hot IPOs include Airbnb, DoorDash, Roblox and Wish…. Read more

This Vaccine Is ONLY 70% Effective

News on the AstraZeneca vaccine gave market sentiment another booster shot today. AstraZeneca (NASDAQ: AZN) announced that its Covid-19 vaccine candidate appears “highly effective” in preventing infection. Its partner… Read more

This Animal Is a Virus Super-Spreader

Is the next Wuhan already occurring in Denmark? Denmark has locked down its north-west region until Dec. 3.  The government wants to stop the rise of a virus potentially… Read more

The Next SalesForce Pre-IPO for 620% Gains

SalesForce (NYSE: CRM) just scored another +$1 billion gain . . . By purchasing Pre-IPO shares of Snowflake (NYSE: SNOW). Shares of Snowflake have surged 126% since its September… Read more

George Soros HATES This Stock After Making $175 Million

George Soros is one of the world’s best hedge fund managers. Back in 2012, his investment fund bought private Pre-IPO shares of Palantir (NYSE: PLTR). Palantir was valued at… Read more

Dr. Fauci Says Cancel Thanksgiving

The United States passed a grim milestone yesterday: 250,000 deaths from Covid-19. Our immediate future looks just as dark. The U.S. reported 163,075 coronavirus cases on Wednesday, pushing the… Read more

Can Robots STOP the Virus?

Scientists have worried that Covid-19 immunity may not be long lasting, but a new study delivers some good news. Researchers from the La Jolla Institute for Immunology looked at… Read more

To top